Rene Bernards Lixte Biotechnology Holdings, Inc. (LIXT) insider trading activity

LIXT Quotes by TradingView

Rene Bernards is Director of LIXTE BIOTECHNOLOGY HOLDINGS, INC.. Currently has a direct ownership of 20,000 shares of LIXT, which is worth approximately $37,800. The most recent transaction as insider was on Oct 03, 2023, when has been sold 5,527 shares (Common Stock) at a price of $2.51 per share, resulting in proceeds of $13,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K
0% 3M change
86.67% 12M change
Total Value Held $37,800

Rene Bernards Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2023
BUY
Open market or private purchase
$13,872 $2.51 p/Share
5,527 Added 21.65%
20,000 Common Stock
Oct 02 2023
BUY
Open market or private purchase
$10,243 $2.29 p/Share
4,473 Added 18.68%
19,472 Common Stock
Dec 15 2022
BUY
Open market or private purchase
$7,650 $0.51 p/Share
15,000 Added 9.09%
150,000 Common Stock
Dec 12 2022
BUY
Open market or private purchase
$6,100 $0.61 p/Share
10,000 Added 6.9%
135,000 Common Stock
Nov 14 2022
BUY
Open market or private purchase
$27,825 $0.53 p/Share
52,500 Added 29.58%
125,000 Common Stock
RB

Rene Bernards

Director
Abcoude, P7

Track Institutional and Insider Activities on LIXT

Follow LIXTE BIOTECHNOLOGY HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LIXT shares.

Notify only if

Insider Trading

Get notified when an Lixte Biotechnology Holdings, Inc. insider buys or sells LIXT shares.

Notify only if

News

Receive news related to LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LIXT